ArticleBMC urology2025
The relationship between the triglyceride glucose-waist height ratio and benign prostatic hyperplasia in middle-aged and elderly adults: a nationwide cohort study.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCurrently, evidence regarding the relationship between variations in the Triglyceride Glucose-Waist-to-Height Ratio (TyG-WHtR) and benign prostatic hyperplasia (BPH) remains scarce. This study aimed to examine the potential association between alterations in TyG-WHtR and the risk of developing BPH.
methodsThis study enrolled 3,296 male participants aged ≥ 45 years from the China Health and Retirement Longitudinal Study (CHARLS). Multivariable logistic regression analysis combined with restricted cubic spline models was employed to explore the potential relationship between TyG-WHtR variation and the risk of developing BPH.
resultsOver a 4-year follow-up period, 267 individuals were diagnosed with BPH. Elevated TyG-WHtR values were significantly associated with a higher risk of BPH (OR = 1.20, 95% CI: 1.02-1.43, p = 0.031), demonstrating a clear dose-response trend (p = 0.01). Furthermore, subgroup analyses revealed that this positive correlation between TyG-WHtR and BPH risk was consistently observed across multiple stratifications.
conclusionThese findings highlight the potential metabolic links between TyG-WHtR and BPH, and underscore the need for future longitudinal studies to explore whether targeting these pathways may aid in BPH prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.